Globus Medical, Inc.
GMED
$57.99
-$0.26-0.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 598.12M | 657.29M | 625.71M | 629.69M | 606.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 598.12M | 657.29M | 625.71M | 629.69M | 606.67M |
| Cost of Revenue | 195.35M | 216.11M | 209.78M | 206.34M | 187.82M |
| Gross Profit | 402.77M | 441.18M | 415.93M | 423.35M | 418.85M |
| SG&A Expenses | 242.80M | 253.39M | 240.49M | 238.07M | 248.68M |
| Depreciation & Amortization | 28.80M | 29.91M | 30.08M | 29.71M | 29.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 500.01M | 532.76M | 515.15M | 511.79M | 523.44M |
| Operating Income | 98.11M | 124.53M | 110.55M | 117.90M | 83.23M |
| Income Before Tax | 103.67M | 24.67M | 57.03M | 47.58M | -8.56M |
| Income Tax Expenses | 28.21M | -1.84M | 5.20M | 15.82M | -1.44M |
| Earnings from Continuing Operations | 75.46M | 26.51M | 51.84M | 31.76M | -7.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.46M | 26.51M | 51.84M | 31.76M | -7.12M |
| EBIT | 98.11M | 124.53M | 110.55M | 117.90M | 83.23M |
| EBITDA | 164.25M | 192.76M | 177.50M | 181.49M | 138.62M |
| EPS Basic | 0.55 | 0.19 | 0.38 | 0.23 | -0.05 |
| Normalized Basic EPS | 0.48 | 0.40 | 0.55 | 0.54 | 0.31 |
| EPS Diluted | 0.54 | 0.19 | 0.38 | 0.23 | -0.05 |
| Normalized Diluted EPS | 0.47 | 0.40 | 0.54 | 0.53 | 0.31 |
| Average Basic Shares Outstanding | 136.76M | 136.73M | 135.62M | 135.20M | 135.36M |
| Average Diluted Shares Outstanding | 139.77M | 139.71M | 138.06M | 136.98M | 135.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |